healthcare conferences

Partners

HSC (Germany) ,

Institute of Clinical Research,

First Clinical Research LLC,

GCP Association,

International Biopharmaceutical Association

Outsourcing

Distribution

Financial benefits with NBScience outsourcing in Eastern Europe:

• Immediate cost reductions and the increased ability to accurately forecast future costs.

• Improved service levels and responsiveness to business needs.

• Affords the manufacturer the ability to focus on core business functions.

• Allows the manufacturer greater flexibility and responsiveness to accommodate change, such as the introduction of a new product line, which requires special handling requirements without having to build that capability and develop the expertise internally.

• Developing a "virtual" business model is attractive to capital markets and may make it easier to source additional financing for expansion or future development.

Article "Russian Pharmaceutical market"

Polish pharmaceutical market value, 2002 - 2007

The total value of the Polish pharmacy market in 2007 was PLN 21.6bn (�5.7bn), 5.8% more than in 2006.

The non-prescription medicines market, which accounts for about one-third of the total market value, was worth PLN 6.6bn (�1.74bn) in 2007, representing a 15.8% increase relative to the previous year. This value includes drugs and non-drugs such as dietary supplements, cosmetics, dressings, dental materials, diagnostic tests and medical devices. The prescription medicines market was worth PLN 15bn (�3.9bn), which represents a 6.4% growth year on year.

Detailed figures are shown in the table below:

	2002	2003	2004	2005	2006	2007
Total pharmacy market (PLN m)	16,2	17,1	17,6	18,9	20,4	21,6
Year-on-year growth	-	5.9%	2.9%	7.3%	7.9%	5,8%
Total OTC market (PLN bn)	4,7	4,8	5,1	5,5	5,7	6,6
Year-on-year growth	-	1.9%	7.2%	7.9%	4.4%	15,8%
Pharmacy Rx market (PLN bn)	11.48	12.27	12.47	13.28	14.1	15,0
Y-o-y change	-	6.90%	1.60%	6.50%	6.3%	6.4%
Refunded drugs (PLN bn)	8.2	9.0	9.0	9.6	10.1	10.1
Y-o-y change	-	9.4%	0.0%	6.7%	5.9%	-0.3%

Note: retail price level

Source: PMR Publications, PharmaExpert, 2008

Article " Drugs and Pharmaceutical Market in Ukraine"

"LAW OF UKRAINE "ON MEDICINES" № 124/96-ВР of 04.04.96"

"Decree of the Cabinet of Ministers of Ukraine of May 26, 2005 № 376"

The success of the NBScience international is built on forging profitable business relationships between the Pharmaceutical and Biotechnology industries and their partners in clinical research.
With our 5 years of experience in increasing our partners' return on investment we've developed winning strategies guaranteed to build and sustain successful partnerships in clinical trials outsourcing.

pharmaceutical companies
CRO
Investigators
GCP,cGMP auditors

NBScience already has many partnerships with societies, universities, statutory organisations and NGOs locally, nationally and internationally. We aim to strengthen these relationships and develop new collaborations in the future.

Clinical Trials Registry

Good Clinical Practice (GCP) Certification Program Participants List

NBScience international

Western Europe

Eastern Europe

clinical trials,CRA,
CRO,GCP,ICH,ICH-GCP,
GLP,GMP,CRP,CRM,
CR,CMO,FDA,EFGCP,
ESMO,CME,clinical trial,
clinical research,
clinical research associate,
good clinical practice,
international conference
harmonization,
good laboratory practice,
good manufacturing practice,
clinical research monitor,
credit medical education,
certification,
online gcp,
online education,
medical conference,
congress,meeting,
medical event,symposium,
medical abstract,registry,
pharmaceutical company,
investigator,
auditor,gcp audit,
gmp audit,glp audit,
cGMP